* Zobrazit nápovědu

Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination. These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations

Konspekt
Patologie. Klinická medicína
NLK Obory
infekční lékařství
NLK Publikační typ
publikace WHO

Kniha

Virové hepatitidy

Praha : Thomayerova nemocnice, [2016]

4 nečíslované strany : ilustrace ; 21 cm

Leták se zabývá virovými hepatitidami A a B a jejich prevencí.

Kniha

HIV a koinfekce : informace pro pacienta

[Praha] : Česká společnost AIDS pomoc, [2015]

Dříve + nyní

11 stran ; 21 cm

MeSH
hepatitida B diagnóza imunologie terapie MeSH
hepatitida C diagnóza imunologie terapie MeSH
HIV infekce MeSH
koinfekce MeSH
sexuálně přenosné nemoci diagnóza imunologie terapie MeSH
tuberkulóza diagnóza imunologie terapie MeSH
vzdělávání pacientů jako téma MeSH
Publikační typ
informační letáky pro pacienty MeSH

Konspekt
Patologie. Klinická medicína
NLK Obory
infekční lékařství
NLK Publikační typ
brožury

E-kniha

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection : March 2015

Světová zdravotnická organizace
Autor Autorita

Geneva : World Health Organization, 2015

Guidelines

xxx, 134 stran : ilustrace, tabulky

These are the first World Health Organization (WHO) guidelines for the prevention, care and treatment of persons living with chronic hepatitis B (CHB) infection, and complement similar recently published guidance by WHO on the prevention, care and treatment of infection due to the hepatitis C virus (HCV). The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2-11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015. These recommendations provide opportunities to save lives, improve clinical outcomes of persons living with CHB, reduce HBV incidence and transmission, and stigma due to disease, but they also pose practical challenges to policymakers and implementers in low- and middle-income countries.--Publisher description.